Showing results (141-150 of 492) with videos related to
Sort By:
Pageof 50
Annals of Surgical Oncology|December 14, 2022
Association of Viral Hepatitis Status and Post-hepatectomy Outcomes in the Era of Direct-Acting AntiviralsLuckshi Rajendran, Woo Jin Choi, Hala Muaddi, et al.Hepatology (Baltimore, Md.)|March 13, 2024
Feasibility of hepatitis C elimination by screening and treatment alone in high-income countriesFeng Tian, Farinaz Forouzannia, Zeny Feng, et al.Journal of Hepatology|December 15, 2010
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utilityNatasha K Martin, Peter Vickerman, Graham R Foster, et al.BMC Medicine|April 2, 2019
Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support interventionHelen R Stagg, Julian Surey, Marie Francis, et al.Journal of Viral Hepatitis|January 9, 2025
Resistance-Associated Substitution Testing Trends and Impact on HCV Treatment Outcomes in Canada: A CanHepC-CANUHC AnalysisHimain Perera, Haris Imsirovic, Gisela Macphail, et al.The Journal of Infectious Diseases|October 31, 2024
Hepatitis B Virus RNA as a Biomarker for Safe Antiviral Discontinuation: A Prospective Study of Nucleos(t)ide Analogue WithdrawalNorah A Terrault, Richard Sterling, Anna S Lok, et al.Infectious Diseases and Therapy|February 17, 2022
Efficacy and Safety of 8- or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal HypertensionRobert S Brown, Michelle A Collins, Simone I Strasser, et al.Paediatrics & Child Health|September 8, 2025
Hepatitis C virus testing in infants, a move to early screening by HCV RNA at 2 months of ageMia J Biondi, Jennifer Flemming, Jennifer van Gennip, et al.JHEP Reports : Innovation in Hepatology|December 1, 2025
Development of a CRE/CREB-driven HBx responsive HBV cell culture reporter system for antiviral drug evaluationMuhammad Atif Zahoor, Nahla FadlElMawla, Adrian Kuipery, et al.Journal of Hepatology|August 27, 2013
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?Adriaan J van der Meer, Heiner Wedemeyer, Jordan J Feld, et al.Pageof 50